about
Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25- regulatory T cellsCis- and trans-acting gene regulation is associated with osteoarthritisDecrease in expression of bone morphogenetic proteins 4 and 5 in synovial tissue of patients with osteoarthritis and rheumatoid arthritisPerspectives and limitations of gene expression profiling in rheumatology: new molecular strategiesAssessment of unspecific near-infrared dyes in laser-induced fluorescence imaging of experimental arthritis.Differential gene expression in the periprosthetic membrane: lubricin as a new possible pathogenetic factor in prosthesis loosening.Preanalytical variables and performance of diagnostic RNA-based gene expression analysis in breast cancer.Morphological and molecular pathology of the B cell response in synovitis of rheumatoid arthritis.Array technology and proteomics in autoimmune diseases.BMP-2 Dependent Increase of Soft Tissue Density in Arthrofibrotic TKA.Autoregulation of Th1-mediated inflammation by twist1.Primary peripheral primitive neuroectodermal tumor/Ewing's tumor of the testis in a 46-year-old man-differential diagnosis and review of the literature.Synovial tissues concentrate secreted APRIL.Impaired wound-healing, local eczema, and chronic inflammation following titanium osteosynthesis in a nickel and cobalt-allergic patient: a case report and review of the literature.Multicentric giant cell tumor of bone: synchronous and metachronous presentationDiagnosis of periprosthetic joint infection.Amyloid arthropathy associated with multiple myeloma: polyarthritis without synovial infiltration of CD20+ or CD38+ cells.De novo expression of EphA2 in osteosarcoma modulates activation of the mitogenic signalling pathway.Giant cell tumors of the bone: molecular profiling and expression analysis of Ephrin A1 receptor, Claudin 7, CD52, FGFR3 and AMFR.Supramacroparticulate PE in 6 different joint endoprostheses localisations: An indicator for PE damage?Cellular analyses in the monitoring of autoimmune diseases.Magnetic drug targeting in a rhabdomyosarcoma rat model using magnetite-dextran composite nanoparticle-bound mitoxantrone and 0.6 tesla extracorporeal magnets - sarcoma treatment in progress.Therapeutic potential of CAMPATH-1H in skeletal tumours.Synovial tissue of the hip at power Doppler US: correlation between vascularity and power Doppler US signal.Growth characterization of neo porcine cartilage pellets and their use in an interactive culture model.Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo.Bonding the foe - NETting neutrophils immobilize the pro-inflammatory monosodium urate crystals.Patients with intolerance reactions to total knee replacement: combined assessment of allergy diagnostics, periprosthetic histology, and peri-implant cytokine expression pattern.Cell-wall alterations as an attribute of Mycobacterium tuberculosis in latent infection.Immunization with glucose-6-phosphate isomerase induces T cell-dependent peripheral polyarthritis in genetically unaltered mice.Differential effects of ethanol on IFN-gamma- and TNF-alpha-producing splenic T lymphocytes in a murine model of gram-negative pneumonia.Expression of CD9, CD11b, CD18, CD52 and PDGFR-beta in the interface membrane of loose endoprostheses.Twenty-three neutrophil granulocytes in 10 high-power fields is the best histopathological threshold to differentiate between aseptic and septic endoprosthesis loosening.
P50
Q24538658-46536C9B-403C-4949-B938-AC528CF3F6C2Q24546386-E892C78E-6A94-4BB4-B7F5-3F109CD50380Q24684384-65830A72-56A0-4361-812C-00B212F6197BQ24805489-7AE86200-2C9E-4E2D-A194-1F38ED142389Q30805500-C73D856C-C09C-40CA-A1C8-42FC0C5EB047Q34202506-26B835C8-0265-48C9-AE96-C19E35B88F03Q34271033-340CE0C4-1181-4237-8FDD-B1C229D00665Q35007175-FFD2CAB9-CE91-434C-B070-199B2BA9B656Q35828108-ECC58073-564B-465D-A04F-2748711E43F3Q35982509-62113CE8-B96D-47DA-B5D6-C6E0A742419AQ36851881-3352F2EE-6A8C-46B4-9191-02C3FC3789F6Q37408651-F5FE172A-A886-402F-8DED-F36345077EABQ37454022-ED2A6929-F074-41A8-B5A1-576087940605Q37886770-32633810-97A5-4596-81F3-9639E81F9E41Q38150852-0BD417D3-37B6-49CB-B85B-1C82C2927DBAQ38171596-05A667BF-EA33-428B-87D5-FA22DE8F1E8CQ38297184-DBE181A3-4DBA-4530-AA4A-B48BA9A9F216Q38338639-91655C53-8416-403F-8BDC-9C4A89F6B80BQ38519438-F4B3C5E2-A231-4450-9805-20F8AEB8EAEBQ38731691-C6C3DAD2-6491-481E-8D96-9E3766164469Q38890389-83D4CC2C-C673-4451-AB44-2FDC36A6B3A4Q39449640-80D8373A-4906-4E24-AEA9-CE1F2E30808FQ39618911-95BD0E96-DB62-4E12-95A6-14C4299F4CC6Q39632059-935A1EB2-0C88-4C1C-A50F-33A0D04C2400Q40416100-F394CB35-630C-4548-9F49-EC7404B707DDQ42210265-0C2448A6-48D7-4EAC-8D2C-ED8FDF118AC7Q42401154-4A672779-B430-428F-8B27-AE16EA2C29DEQ43214310-8844B7E0-5129-4A94-9240-77E7A510911AQ44639570-10CBBA56-E92C-4C9A-A5FE-5C6A6322D782Q44807490-8737BA53-4AE7-4477-8684-E032448FBDA8Q44821759-619A0364-2C56-4E89-B98E-F69688FEBFDFQ45222434-A39DC24E-1B8C-44B1-9AE4-467F4A35E404Q45918820-6923261F-CB93-4D8D-ABE4-E802BF39424F
P50
description
onderzoeker
@nl
name
Veit Krenn
@ast
Veit Krenn
@en
Veit Krenn
@es
Veit Krenn
@nl
Veit Krenn
@sl
type
label
Veit Krenn
@ast
Veit Krenn
@en
Veit Krenn
@es
Veit Krenn
@nl
Veit Krenn
@sl
prefLabel
Veit Krenn
@ast
Veit Krenn
@en
Veit Krenn
@es
Veit Krenn
@nl
Veit Krenn
@sl
P106
P21
P31
P569
2000-01-01T00:00:00Z